UnitedHealth Group held its annual shareholder meeting, where shareholders re-elected all directors and approved a new compensation package for CEO Stephen Hemsley, including $60 million in stock and a $1 million annual salary. Hemsley, who returned as CEO in May after Andrew Witty stepped down, addressed the company's first earnings miss since 2008 and stated the company will review its practices, particularly in its Medicare Advantage unit. The board authorized a quarterly dividend increase to $2.21 per share, payable on June 24, 2025. Shareholders also ratified Deloitte & Touche LLP as the company's independent auditor and voted against a proposal to limit golden parachute payments. Proxy advisory firms were split on Hemsley's pay package. The company is evaluating a potential Optum-UnitedHealthcare split and reviewing its leadership structure and pricing. UnitedHealth's stock has declined 40% year-to-date, with a $250 billion loss in market capitalization since its November peak. An internal document, mistakenly sent to STAT and authored by Casey Ross, Tara Bannow, and Bob Herman, detailed how executives prepared to address investor concerns at the meeting, including missed revenue targets, lawsuits, federal investigations, and criticism over the use of artificial intelligence and administrative barriers to delay or deny care. The meeting followed the December 2024 killing of UnitedHealthcare CEO Brian Thompson, which has led to additional scrutiny and a class action lawsuit alleging the company concealed losses related to changes in claims denial strategies.